Clinical trial
An Initial Assessment of the Safety and Performance of the Sphere-9™ Catheter and System for Mapping and Ablation of Atrial Arrhythmias
NCT04210622 is registered in ClinicalTrials.gov with Medtronic Cardiac Ablation Solutions as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Initial Assessment of the Safety and Performance of the Sphere-9™ Catheter and System for Mapping and Ablation of Atrial Arrhythmias
- Lead sponsor
- Medtronic Cardiac Ablation Solutions
- Phase
- Not reported
- Overall status
- Completed
- Start date
- May 1, 2018
- Completion date
- June 18, 2020
- Enrollment
- 16 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.